Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Amma Owusu-Ansah, MD

Amma Owusu-Ansah, MD

  • Specialty: Pediatric Hematology and Oncology
    View Expertise
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Rainbow Babies & Children's Hospital (0 mi.)

11100 Euclid Ave
8th Floor
Cleveland, OH 44106
216-844-1443

UH RBC Solon Health Center (12 mi.)

34055 Solon Rd
Ste 200
Solon, OH 44139
216-844-2273

UH RBC Perrico Health Center (15 mi.)

4176 State Route 306
Ste 300
Willoughby, OH 44094
216-844-2273

UH N Ridgeville Health Center (21 mi.)

32800 Lorain Rd
Ste 2200
North Ridgeville, OH 44039
216-844-2273

Biography: Amma Owusu-Ansah, MD

Expertise

  • Benign Hematology
  • Global Hematology
  • Sickle Cell Disease

Titles

  • Director, Pediatric Sickle Cell Anemia Center, UH Rainbow Babies and Children's Hospital

Certifications & Memberships

  • Pediatric Hematology-Oncology - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics

Education

Research Fellowship | Hematology/Oncology
Hematology/Oncology - UH Case Medical Center (2012 - 2014)

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - Uh Case Medical Center (2009 - 2012)

Residency | Pediatrics
Pediatrics - John H Stroger, Jr Hospital Of Cook County (2001 - 2004)

Medical Education
University Of Ghana (1997)

Related Blog Articles

Illustration of sickle cell anemia

The Invisible Toll of Living with Sickle Cell Disease

People living with sickle cell disease face a host of daunting physical challenges that affect their quality of life.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Amma Owusu-Ansah did not disclose any Outside Relationships with Industry.